Cadrenal Therapeutics, Inc.

New Filing
CIK: 0001937993·Biotechnology·DELAWARE·Filed: Nov 14, 2024
Total Offering

$9,428,594

Amount Sold

$9,428,594

Investors

5

First Sale

Nov 1, 2024

Offering Details

Type
Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2022
Non-Accredited Investors
Yes

Related Persons

NameRole
Quang Pham
Related Person
Matthew Szot
Related Person
Douglas W. Losordo
Related Person
Jeff Cole
Related Person
STEVEN ZELENKOFSKE
Related Person
GLYNN WILSON
Related Person
Robert Lisicki
Related Person
JOHN R. MURPHY
Related Person

Company

Cadrenal Therapeutics, Inc.

822 A1A NORTH, SUITE 306

PONTE VEDRA, FL, 32082

(904) 300-0701

SEC Filing

0001213900-24-097866

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free